Definium Therapeutics, Inc. (DFTX)
38.44
-0.24
(-0.62%)
USD |
NASDAQ |
Sep 18, 10:32
Definium Therapeutics Market Cap : 5.165B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 5.197B |
| September 16, 2026 | 5.086B |
| September 15, 2026 | 4.947B |
| September 14, 2026 | 5.408B |
| September 11, 2026 | 5.225B |
| September 10, 2026 | 5.070B |
| September 09, 2026 | 5.105B |
| September 08, 2026 | 5.137B |
| September 04, 2026 | 5.118B |
| September 03, 2026 | 5.106B |
| September 02, 2026 | 5.227B |
| September 01, 2026 | 5.173B |
| August 31, 2026 | 5.337B |
| August 28, 2026 | 5.506B |
| August 27, 2026 | 5.888B |
| August 26, 2026 | 5.881B |
| August 25, 2026 | 6.021B |
| August 24, 2026 | 5.814B |
| August 21, 2026 | 6.034B |
| August 20, 2026 | 6.100B |
| August 19, 2026 | 6.157B |
| August 18, 2026 | 6.205B |
| August 17, 2026 | 6.081B |
| August 14, 2026 | 5.728B |
| August 13, 2026 | 5.899B |
| Date | Value |
|---|---|
| August 12, 2026 | 5.750B |
| August 11, 2026 | 5.497B |
| August 10, 2026 | 6.067B |
| August 07, 2026 | 6.200B |
| August 06, 2026 | 6.200B |
| August 05, 2026 | 5.965B |
| August 04, 2026 | 5.686B |
| August 03, 2026 | 4.348B |
| July 31, 2026 | 4.528B |
| July 30, 2026 | 4.629B |
| July 29, 2026 | 4.387B |
| July 28, 2026 | 4.366B |
| July 27, 2026 | 4.437B |
| July 24, 2026 | 4.492B |
| July 23, 2026 | 4.467B |
| July 22, 2026 | 4.544B |
| July 21, 2026 | 4.690B |
| July 20, 2026 | 4.453B |
| July 17, 2026 | 4.608B |
| July 16, 2026 | 4.588B |
| July 15, 2026 | 4.751B |
| July 14, 2026 | 4.784B |
| July 13, 2026 | 4.542B |
| July 10, 2026 | 4.897B |
| July 09, 2026 | 5.041B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 16.13M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0814M |
| Arvinas, Inc. | 538.72M |
| Fulcrum Therapeutics, Inc. | 288.36M |
Market Cap Related Metrics
| PEG Ratio | -0.0829 |
| Price to Book Value | 5.622 |
| Price | 38.44 |
| Earnings Yield | -8.95% |
| PEGY Ratio | -0.0829 |